Schwarz Pharma Has Approvable FDA Letter For Neupro

Published: Mar 01, 2006

FRANKFURT, March 1 (Reuters) - Schwarz Pharma's (SRZG.DE: Quote, Profile, Research) Neupro drug for the treatment of early Parkinson's disease has won an approvable letter from the U.S. Food and Drug Administration (FDA), the German company said on Wednesday.

Back to news